Dhomen, Nathalie
University of Manchester
4 papers on CoChatORCID 0000-0003-1961-2173
Most cited papers
- Verified
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Lee, K. A., Thomas, A. M., Bolte, L. A., Björk, J. R., de Ruijter, L. K., Armanini, F., Asnicar, F., Blanco-Miguez, A., Board, R., Calbet-Llopart, N., et al. (2022) · Nature Medicine
Cancer Immunotherapy and BiomarkersGut microbiota and health
Cited by 464
- Verified
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
Viros, A., Sanchez-Laorden, B., Pedersen, M., Furney, S. J., Rae, J., Hogan, K., Ejiama, S., Girotti, M. R., Cook, M., Dhomen, N., et al. (2014) · Nature
Melanoma and MAPK PathwaysSkin Protection and Aging
Cited by 249
- Verified
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Björk, J. R., Bolte, L. A., Maltez Thomas, A., Lee, K. A., Rossi, N., Wind, T. T., Smit, L. M., Armanini, F., Asnicar, F., Blanco-Miguez, A., et al. (2024) · Nature Medicine
Gut microbiota and healthCancer Immunotherapy and Biomarkers
Cited by 156
- Verified
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers
Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., et al. (2021) · Annals of Oncology
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free